ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

HHS Appeals Board Finds No Misconduct By Popovic

November 12, 1993

Markup Of Cancer Act Renewal Set For Mid-October

September 21, 1979

In Brief: Cancer Bill Nearly Became Law Without Nixon’s Signature as Impeachment Obsesses White House

August 2, 1974

Zydelig Tablets Approved For Three Blood Cancers

July 25, 2014

Survey Shows That One-Third Of Patients Are Undertreated

April 27, 2012

NCI Says. President Bush Visits NIH, Marks Decline In U.S. Cancer Deaths For Second Year.

January 19, 2007